Interaction between postoperative shivering and hyperalgesia caused by high-dose remifentanil

Korean Journal of Anesthesiology 2014³â 66±Ç 1È£ p.44 ~ p.51

¼ÕÀ±°­(Song Yoon-Kang) - Wonkwang University College of Medicine Department of Anesthesiology and Pain Medicine
ÀÌö(Lee Cheol) - Wonkwang University College of Medicine Department of Anesthesiology and Pain Medicine
¼­µ¿Çõ(Seo Dong-Hyuk) - Wonkwang University College of Medicine Department of Anesthesiology and Pain Medicine
¹Ú¼º³²(Park Seong-Nam) - Wonkwang University College of Medicine Departments of Obstetrics and Gynecology
¹®¼­¿µ(Moon Seo-Young) - Wonkwang University Sanbon Hospital Department of Anesthesiology and Pain Medicine
¹ÚâÇö(Park Chang-Hyun) - Presbyterian Medical Center

Abstract

Background: High-dose remifentanil-based anesthesia is associated with opioid-induced hyperalgesia (OIH) and postanesthetic shivering (PAS). These effects can be prevented by N-methyl-d-aspartate (NMDA) receptor antagonists. This study aimed to investigate correlations between OIH and PAS caused by high-dose remifentanil and the effects of low-dose ketamine on OIH and PAS.

Methods: Seventy-five patients scheduled for single-port laparoscopic gynecologic surgery were randomly allocated into three groups, each of which received intraoperative remifentanil: group L at 0.1 ¥ìg/kg/min; group H at 0.3 ¥ìg/kg/min; and group HK at 0.3 ¥ìg/kg/min plus 0.25 mg/kg ketamine just before incision, followed by a continuous infusion of 5 ¥ìg/kg/min ketamine until skin closure.

Results: PAS, postoperative tactile pain threshold, and the extent of hyperalgesia in group H were significantly different (P < 0.05) than in the other two groups. PAS was significantly correlated with OIH, including mechanically evoked pain such as postoperative tactile pain threshold (r = -0.529, P = 0.01) (r = -0.458, P = 0.021) and the extent of hyperalgesia (r = 0.537, P = 0.002) (r = 0.384, P = 0.031), respectively, in group H and group HK. Notably, both groups were treated with high-dose remifentanil. Tympanic membrane temperature, time to first postoperative analgesic requirement, postoperative pain scores, analgesic consumption, and cumulative patient-controlled analgesia volume containing morphine were comparable in all three groups.

Conclusions: OIH, including the enhanced perception of pain, and PAS were both associated with high-dose remifentanil, were significantly correlated and were attenuated by a low dose of ketamine. This suggests that a common mechanism in part mediated through activation of the central glutamatergic system (e.g., NMDA receptors), underlies the two effects caused by high doses of remifentanil.

Ű¿öµå

Ketamine, Opioid-induced hyperalgesia, Postanesthetic shivering, Remifentanil
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
MEDLINE ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø 
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Ű¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆÇ³âµµ(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå